The anti-inflammatory effects of KrocinaTM have been identified in patients with osteoarthritis by reducing C-reactive protein (CRP) and interleukin (IL)-17 levels (Poursamimi et al., 2020). This evidence concerns the gene CRP and osteoarthritis.